Placebo (physiological saline) ( DrugBank: - )
2 diseases
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
43 | 顕微鏡的多発血管炎 | 1 |
45 | 好酸球性多発血管炎性肉芽腫症 | 1 |
43. 顕微鏡的多発血管炎
臨床試験数 : 88 / 薬物数 : 81 - (DrugBank : 21) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 90
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | JPRN-JapicCTI-132394 | 07/3/2014 | 25/12/2013 | Phase 3 study of GGS in patients with microscopic polyangiitis (MPA) | Randomized, placebo-controlled, double-blind, parallel-group clinical study of GGS in patients with microscopic polyangiitis (MPA) (Phase 3 study) | Microscopic polyangiitis (MPA) | Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) INN of the intervention : - Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : Placebo (physiological saline) INN of the control intervention : - Dosage And administration of the control intervention : Intravenous drip infusion | TEIJIN PHARMA LIMITED | NULL | complete | 20 | BOTH | 36 | Phase 3 | Japan |
45. 好酸球性多発血管炎性肉芽腫症
臨床試験数 : 31 / 薬物数 : 44 - (DrugBank : 18) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 101
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | JPRN-JapicCTI-060242 | 01/2/2006 | Phase 3 study of GGS in patients with CSS/AGA | Double-blind, Randomized clinical study of GGS (Intravenous Immunoglobulin) in patients with CSS/AGA. Phase 3 study. | Churg-Strauss Syndrome (CSS) / Allergic Granulomatous Angiitis (AGA) | Intervention name : Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) Dosage And administration of the intervention : Intravenous drip infusion Control intervention name : Placebo (physiological saline) Dosage And administration of the control intervention : Intravenous drip infusion | TEIJIN PHARMA LIMITED | NULL | 20 | 74 | BOTH | 21 | Phase 3 | NULL |